Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

Prof Prakash Naidoo appointed as Vice-Rector: Operations
2017-09-13

 Description: Prof Prakash read more Tags: Prof Prakash Naidoo, Prakash Naidoo, Vice-Rector: Operations, Qwaqwa Campus Principal 

Prof Prakash Naidoo has been appointed
as Vice-Rector: Operations
Photo: Stephen Collet



The Council of the University of the Free State (UFS) approved the appointment of Prof Prakash Naidoo as Vice-Rector: Operations, during its quarterly meeting held on the South Campus in Bloemfontein on 8 September 2017.

Prof Naidoo is a former Deputy Vice-Chancellor: Resources and Planning at the Vaal University of Technology (VUT). He has also been the Executive Dean: Faculty of Management Sciences at VUT. Prior to this, he was a lecturer in the Department of Accounting at the Durban University of Technology (DUT), and Vice-Dean and Acting Dean of the Faculty of Commerce at DUT.
“Prof Naidoo is a seasoned senior manager and an excellent appointment in this vital position. He understands the higher-education sector, and the Council is satisfied by the quality and extent of experience which he will bring to the position,” said Mr Willem Louw, Chairperson of the UFS Council. 

He holds a PhD in Management Accounting, MComm in Management Accounting, Honours in Accounting, Honours in Economics, BComm (Acc), and a University Diploma in Education.

Prof Naidoo is a registered professional accountant with the South African Institute of Professional Accountants (SAIPA), an associate of the Chartered Institute of Business Management (CIBM), and an Internationally Certified Fraud Examiner (ACFE). He was also an international associate of the American Institute of Certified Public Accountants (AICPA).
He served as member and chairperson on various boards and forums, including the Investment Committee of the National Tertiary Retirement Fund (NTRF); Audit Committee of the National Institute on Higher Education in Mpumalanga (NIHE); Audit Committee of the Higher Education Purchasing Consortium (PURCO), and other task teams in higher education. He also served as a former director of ACFE (SA Chapter), where he received a commendation for his work in fighting fraud and corruption in the country. He has written and published numerous papers, supervised research, presented papers at conferences, and published one book.
Prof Naidoo is currently the Campus Principal of the university’s Qwaqwa Campus. He will start in the new position as from 1 January 2018, following the subsequent retirement of Prof Nicky Morgan, current Vice-Rector: Operations at the end of December 2017.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept